|

DBC-664 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Duboce Biopharmaceuticals, Inc.1

Indications

  • Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma1
  • Ovarian Adenocarcinoma1
  • Lung Adenocarcinoma1
  • Malignant Germ Cell Tumor1
  • Urothelial Carcinoma1

Grand Rapids, Michigan1 trial

DBC-664 in Adult Patients With Solid Tumors Associated

START Midwest

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.